nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A1—lung cancer	0.192	0.653	CbGaD
Albendazole—TUBA1A—Vinblastine—lung cancer	0.145	0.265	CbGbCtD
Albendazole—ABCB1—lung cancer	0.102	0.347	CbGaD
Albendazole—TUBB4B—Vinorelbine—lung cancer	0.0899	0.164	CbGbCtD
Albendazole—TUBB4B—Paclitaxel—lung cancer	0.0632	0.115	CbGbCtD
Albendazole—TUBB4B—Vinblastine—lung cancer	0.0554	0.101	CbGbCtD
Albendazole—TUBB4B—Docetaxel—lung cancer	0.0457	0.0833	CbGbCtD
Albendazole—CYP1A1—Gefitinib—lung cancer	0.0213	0.0388	CbGbCtD
Albendazole—CYP1A1—Erlotinib—lung cancer	0.0126	0.0229	CbGbCtD
Albendazole—ABCB1—Topotecan—lung cancer	0.00908	0.0166	CbGbCtD
Albendazole—ABCB1—Gefitinib—lung cancer	0.00831	0.0152	CbGbCtD
Albendazole—ABCB1—Vinorelbine—lung cancer	0.0064	0.0117	CbGbCtD
Albendazole—CYP1A2—Erlotinib—lung cancer	0.00562	0.0103	CbGbCtD
Albendazole—CYP3A4—Topotecan—lung cancer	0.00544	0.00993	CbGbCtD
Albendazole—ABCB1—Crizotinib—lung cancer	0.00509	0.00929	CbGbCtD
Albendazole—CYP3A4—Gefitinib—lung cancer	0.00498	0.00908	CbGbCtD
Albendazole—ABCB1—Gemcitabine—lung cancer	0.00498	0.00908	CbGbCtD
Albendazole—ABCB1—Erlotinib—lung cancer	0.00491	0.00896	CbGbCtD
Albendazole—CYP3A4—Teniposide—lung cancer	0.00483	0.00881	CbGbCtD
Albendazole—ABCB1—Paclitaxel—lung cancer	0.0045	0.00821	CbGbCtD
Albendazole—ABCB1—Irinotecan—lung cancer	0.00444	0.00809	CbGbCtD
Albendazole—CYP1A2—Etoposide—lung cancer	0.00406	0.00741	CbGbCtD
Albendazole—ABCB1—Vinblastine—lung cancer	0.00394	0.0072	CbGbCtD
Albendazole—CYP3A4—Vinorelbine—lung cancer	0.00383	0.007	CbGbCtD
Albendazole—ABCB1—Cisplatin—lung cancer	0.00362	0.0066	CbGbCtD
Albendazole—ABCB1—Etoposide—lung cancer	0.00355	0.00648	CbGbCtD
Albendazole—ABCB1—Docetaxel—lung cancer	0.00325	0.00593	CbGbCtD
Albendazole—CYP3A4—Crizotinib—lung cancer	0.00305	0.00557	CbGbCtD
Albendazole—CYP3A4—Erlotinib—lung cancer	0.00294	0.00537	CbGbCtD
Albendazole—CYP3A4—Paclitaxel—lung cancer	0.00269	0.00492	CbGbCtD
Albendazole—CYP3A4—Irinotecan—lung cancer	0.00266	0.00485	CbGbCtD
Albendazole—ABCB1—Doxorubicin—lung cancer	0.00242	0.00442	CbGbCtD
Albendazole—CYP3A4—Vinblastine—lung cancer	0.00236	0.00431	CbGbCtD
Albendazole—ABCB1—Methotrexate—lung cancer	0.00235	0.00428	CbGbCtD
Albendazole—TUBA1A—mammary gland—lung cancer	0.00224	0.104	CbGeAlD
Albendazole—CYP3A4—Etoposide—lung cancer	0.00213	0.00388	CbGbCtD
Albendazole—CYP3A4—Docetaxel—lung cancer	0.00195	0.00355	CbGbCtD
Albendazole—TUBB4B—mammary gland—lung cancer	0.00149	0.0692	CbGeAlD
Albendazole—TUBA1A—respiratory system—lung cancer	0.00149	0.0692	CbGeAlD
Albendazole—TUBA1A—Zalcitabine—Gemcitabine—lung cancer	0.00149	0.548	CbGdCrCtD
Albendazole—CYP3A4—Doxorubicin—lung cancer	0.00145	0.00265	CbGbCtD
Albendazole—TUBA1A—epithelium—lung cancer	0.00125	0.0578	CbGeAlD
Albendazole—TUBA1A—bronchus—lung cancer	0.00123	0.0569	CbGeAlD
Albendazole—TUBA1A—trachea—lung cancer	0.0011	0.0511	CbGeAlD
Albendazole—TUBA1A—cardiac atrium—lung cancer	0.00103	0.048	CbGeAlD
Albendazole—TUBB4B—respiratory system—lung cancer	0.000993	0.0461	CbGeAlD
Albendazole—TUBB4B—Afatinib—Gefitinib—lung cancer	0.000914	0.337	CbGdCrCtD
Albendazole—TUBA1A—bone marrow—lung cancer	0.000873	0.0405	CbGeAlD
Albendazole—Mebendazole—CYP1A1—lung cancer	0.000855	0.653	CrCbGaD
Albendazole—TUBB4B—bronchus—lung cancer	0.000818	0.0379	CbGeAlD
Albendazole—TUBA1A—lung—lung cancer	0.000791	0.0367	CbGeAlD
Albendazole—TUBB4B—trachea—lung cancer	0.000734	0.0341	CbGeAlD
Albendazole—TUBB4B—cardiac atrium—lung cancer	0.00069	0.032	CbGeAlD
Albendazole—TUBB4B—bone marrow—lung cancer	0.000582	0.027	CbGeAlD
Albendazole—CYP1A2—respiratory system—lung cancer	0.000564	0.0262	CbGeAlD
Albendazole—CYP1A1—respiratory system—lung cancer	0.000556	0.0258	CbGeAlD
Albendazole—TUBA1A—lymph node—lung cancer	0.000541	0.0251	CbGeAlD
Albendazole—TUBB4B—lung—lung cancer	0.000527	0.0245	CbGeAlD
Albendazole—CYP1A1—epithelium—lung cancer	0.000465	0.0216	CbGeAlD
Albendazole—CYP1A1—bronchus—lung cancer	0.000458	0.0212	CbGeAlD
Albendazole—Mebendazole—ABCB1—lung cancer	0.000454	0.347	CrCbGaD
Albendazole—CYP1A1—trachea—lung cancer	0.000411	0.0191	CbGeAlD
Albendazole—CYP1A1—cardiac atrium—lung cancer	0.000386	0.0179	CbGeAlD
Albendazole—TUBB4B—lymph node—lung cancer	0.000361	0.0167	CbGeAlD
Albendazole—TUBA1A—Azacitidine—Gemcitabine—lung cancer	0.000313	0.115	CbGdCrCtD
Albendazole—CYP1A2—lung—lung cancer	0.000299	0.0139	CbGeAlD
Albendazole—CYP1A1—lung—lung cancer	0.000295	0.0137	CbGeAlD
Albendazole—ABCB1—respiratory system—lung cancer	0.000289	0.0134	CbGeAlD
Albendazole—Body temperature increased—Teniposide—lung cancer	0.000272	0.00325	CcSEcCtD
Albendazole—Alopecia—Vinorelbine—lung cancer	0.000272	0.00324	CcSEcCtD
Albendazole—Vomiting—Pemetrexed—lung cancer	0.00027	0.00323	CcSEcCtD
Albendazole—Vomiting—Gefitinib—lung cancer	0.000269	0.0032	CcSEcCtD
Albendazole—Rash—Pemetrexed—lung cancer	0.000268	0.0032	CcSEcCtD
Albendazole—Dermatitis—Pemetrexed—lung cancer	0.000268	0.0032	CcSEcCtD
Albendazole—Rash—Gefitinib—lung cancer	0.000266	0.00318	CcSEcCtD
Albendazole—Dermatitis—Gefitinib—lung cancer	0.000266	0.00317	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.000264	0.00315	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.000262	0.00312	CcSEcCtD
Albendazole—Hepatobiliary disease—Gemcitabine—lung cancer	0.00026	0.0031	CcSEcCtD
Albendazole—Thrombocytopenia—Vinblastine—lung cancer	0.000257	0.00307	CcSEcCtD
Albendazole—Agranulocytosis—Gemcitabine—lung cancer	0.000257	0.00306	CcSEcCtD
Albendazole—Hypersensitivity—Teniposide—lung cancer	0.000254	0.00303	CcSEcCtD
Albendazole—Nausea—Pemetrexed—lung cancer	0.000253	0.00301	CcSEcCtD
Albendazole—Nausea—Gefitinib—lung cancer	0.000251	0.00299	CcSEcCtD
Albendazole—Pancytopenia—Etoposide—lung cancer	0.00025	0.00298	CcSEcCtD
Albendazole—Thrombocytopenia—Topotecan—lung cancer	0.00025	0.00298	CcSEcCtD
Albendazole—Skin disorder—Topotecan—lung cancer	0.000248	0.00296	CcSEcCtD
Albendazole—Thrombocytopenia—Erlotinib—lung cancer	0.000247	0.00295	CcSEcCtD
Albendazole—Neutropenia—Etoposide—lung cancer	0.000246	0.00294	CcSEcCtD
Albendazole—Skin disorder—Erlotinib—lung cancer	0.000245	0.00293	CcSEcCtD
Albendazole—Pancytopenia—Paclitaxel—lung cancer	0.000245	0.00293	CcSEcCtD
Albendazole—Urinary tract disorder—Gemcitabine—lung cancer	0.000244	0.00291	CcSEcCtD
Albendazole—Hepatobiliary disease—Cisplatin—lung cancer	0.000242	0.00289	CcSEcCtD
Albendazole—Urethral disorder—Gemcitabine—lung cancer	0.000242	0.00289	CcSEcCtD
Albendazole—Neutropenia—Paclitaxel—lung cancer	0.000242	0.00288	CcSEcCtD
Albendazole—ABCB1—epithelium—lung cancer	0.000241	0.0112	CbGeAlD
Albendazole—Vertigo—Vinorelbine—lung cancer	0.00024	0.00287	CcSEcCtD
Albendazole—Leukopenia—Vinorelbine—lung cancer	0.000239	0.00286	CcSEcCtD
Albendazole—Aplastic anaemia—Methotrexate—lung cancer	0.000236	0.00282	CcSEcCtD
Albendazole—Liver function test abnormal—Docetaxel—lung cancer	0.000234	0.00279	CcSEcCtD
Albendazole—Erythema multiforme—Gemcitabine—lung cancer	0.000233	0.00279	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Etoposide—lung cancer	0.000233	0.00278	CcSEcCtD
Albendazole—Immune system disorder—Irinotecan—lung cancer	0.000229	0.00273	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.000228	0.00272	CcSEcCtD
Albendazole—Urinary tract disorder—Cisplatin—lung cancer	0.000227	0.00271	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000226	0.0027	CcSEcCtD
Albendazole—Urethral disorder—Cisplatin—lung cancer	0.000226	0.00269	CcSEcCtD
Albendazole—Alopecia—Irinotecan—lung cancer	0.000224	0.00267	CcSEcCtD
Albendazole—Immune system disorder—Gemcitabine—lung cancer	0.000223	0.00266	CcSEcCtD
Albendazole—Hepatobiliary disease—Etoposide—lung cancer	0.000222	0.00265	CcSEcCtD
Albendazole—Agranulocytosis—Etoposide—lung cancer	0.000219	0.00261	CcSEcCtD
Albendazole—Vomiting—Teniposide—lung cancer	0.000219	0.00261	CcSEcCtD
Albendazole—Alopecia—Gemcitabine—lung cancer	0.000218	0.0026	CcSEcCtD
Albendazole—Hepatobiliary disease—Paclitaxel—lung cancer	0.000218	0.0026	CcSEcCtD
Albendazole—Rash—Teniposide—lung cancer	0.000217	0.00259	CcSEcCtD
Albendazole—Dermatitis—Teniposide—lung cancer	0.000217	0.00259	CcSEcCtD
Albendazole—Headache—Teniposide—lung cancer	0.000216	0.00257	CcSEcCtD
Albendazole—Gastrointestinal pain—Vinblastine—lung cancer	0.000215	0.00256	CcSEcCtD
Albendazole—Thrombocytopenia—Vinorelbine—lung cancer	0.000214	0.00255	CcSEcCtD
Albendazole—ABCB1—trachea—lung cancer	0.000213	0.00991	CbGeAlD
Albendazole—Skin disorder—Vinorelbine—lung cancer	0.000212	0.00253	CcSEcCtD
Albendazole—Gastrointestinal pain—Topotecan—lung cancer	0.000209	0.00249	CcSEcCtD
Albendazole—Urinary tract disorder—Etoposide—lung cancer	0.000208	0.00248	CcSEcCtD
Albendazole—Pancytopenia—Docetaxel—lung cancer	0.000208	0.00248	CcSEcCtD
Albendazole—Immune system disorder—Cisplatin—lung cancer	0.000208	0.00248	CcSEcCtD
Albendazole—Abdominal pain—Vinblastine—lung cancer	0.000208	0.00248	CcSEcCtD
Albendazole—Urethral disorder—Etoposide—lung cancer	0.000207	0.00247	CcSEcCtD
Albendazole—Gastrointestinal pain—Erlotinib—lung cancer	0.000207	0.00246	CcSEcCtD
Albendazole—Neutropenia—Docetaxel—lung cancer	0.000205	0.00244	CcSEcCtD
Albendazole—Nausea—Teniposide—lung cancer	0.000205	0.00244	CcSEcCtD
Albendazole—Aplastic anaemia—Doxorubicin—lung cancer	0.000204	0.00244	CcSEcCtD
Albendazole—Urinary tract disorder—Paclitaxel—lung cancer	0.000204	0.00244	CcSEcCtD
Albendazole—Alopecia—Cisplatin—lung cancer	0.000203	0.00243	CcSEcCtD
Albendazole—Urticaria—Topotecan—lung cancer	0.000203	0.00242	CcSEcCtD
Albendazole—Urethral disorder—Paclitaxel—lung cancer	0.000203	0.00242	CcSEcCtD
Albendazole—CYP1A1—lymph node—lung cancer	0.000202	0.00938	CbGeAlD
Albendazole—Body temperature increased—Topotecan—lung cancer	0.000202	0.00241	CcSEcCtD
Albendazole—Abdominal pain—Topotecan—lung cancer	0.000202	0.00241	CcSEcCtD
Albendazole—Body temperature increased—Erlotinib—lung cancer	0.0002	0.00238	CcSEcCtD
Albendazole—Abdominal pain—Erlotinib—lung cancer	0.0002	0.00238	CcSEcCtD
Albendazole—Erythema multiforme—Etoposide—lung cancer	0.000199	0.00238	CcSEcCtD
Albendazole—Vertigo—Irinotecan—lung cancer	0.000198	0.00237	CcSEcCtD
Albendazole—Renal failure acute—Methotrexate—lung cancer	0.000198	0.00236	CcSEcCtD
Albendazole—Leukopenia—Irinotecan—lung cancer	0.000198	0.00236	CcSEcCtD
Albendazole—Erythema multiforme—Paclitaxel—lung cancer	0.000195	0.00233	CcSEcCtD
Albendazole—Hypersensitivity—Vinblastine—lung cancer	0.000194	0.00231	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.000194	0.00231	CcSEcCtD
Albendazole—Leukopenia—Gemcitabine—lung cancer	0.000192	0.0023	CcSEcCtD
Albendazole—Immune system disorder—Etoposide—lung cancer	0.00019	0.00227	CcSEcCtD
Albendazole—Hypersensitivity—Topotecan—lung cancer	0.000188	0.00224	CcSEcCtD
Albendazole—Immune system disorder—Paclitaxel—lung cancer	0.000187	0.00223	CcSEcCtD
Albendazole—Alopecia—Etoposide—lung cancer	0.000186	0.00222	CcSEcCtD
Albendazole—Hepatobiliary disease—Docetaxel—lung cancer	0.000185	0.0022	CcSEcCtD
Albendazole—Alopecia—Paclitaxel—lung cancer	0.000183	0.00218	CcSEcCtD
Albendazole—Agranulocytosis—Docetaxel—lung cancer	0.000182	0.00217	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000182	0.00217	CcSEcCtD
Albendazole—Leukopenia—Cisplatin—lung cancer	0.000179	0.00214	CcSEcCtD
Albendazole—Gastrointestinal pain—Vinorelbine—lung cancer	0.000179	0.00213	CcSEcCtD
Albendazole—Thrombocytopenia—Irinotecan—lung cancer	0.000176	0.0021	CcSEcCtD
Albendazole—Hepatitis—Docetaxel—lung cancer	0.000175	0.00209	CcSEcCtD
Albendazole—Dizziness—Vinblastine—lung cancer	0.000174	0.00207	CcSEcCtD
Albendazole—Urticaria—Vinorelbine—lung cancer	0.000173	0.00207	CcSEcCtD
Albendazole—Urinary tract disorder—Docetaxel—lung cancer	0.000173	0.00206	CcSEcCtD
Albendazole—Body temperature increased—Vinorelbine—lung cancer	0.000173	0.00206	CcSEcCtD
Albendazole—Abdominal pain—Vinorelbine—lung cancer	0.000173	0.00206	CcSEcCtD
Albendazole—Urethral disorder—Docetaxel—lung cancer	0.000172	0.00205	CcSEcCtD
Albendazole—Thrombocytopenia—Gemcitabine—lung cancer	0.000172	0.00205	CcSEcCtD
Albendazole—Renal failure acute—Doxorubicin—lung cancer	0.000171	0.00204	CcSEcCtD
Albendazole—Skin disorder—Gemcitabine—lung cancer	0.00017	0.00203	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000169	0.00202	CcSEcCtD
Albendazole—ABCB1—bone marrow—lung cancer	0.000169	0.00786	CbGeAlD
Albendazole—Dizziness—Topotecan—lung cancer	0.000169	0.00201	CcSEcCtD
Albendazole—Liver function test abnormal—Methotrexate—lung cancer	0.000169	0.00201	CcSEcCtD
Albendazole—Vomiting—Vinblastine—lung cancer	0.000167	0.00199	CcSEcCtD
Albendazole—Dizziness—Erlotinib—lung cancer	0.000167	0.00199	CcSEcCtD
Albendazole—Erythema multiforme—Docetaxel—lung cancer	0.000166	0.00198	CcSEcCtD
Albendazole—Vertigo—Etoposide—lung cancer	0.000165	0.00197	CcSEcCtD
Albendazole—Headache—Vinblastine—lung cancer	0.000165	0.00196	CcSEcCtD
Albendazole—Leukopenia—Etoposide—lung cancer	0.000164	0.00196	CcSEcCtD
Albendazole—Vomiting—Topotecan—lung cancer	0.000162	0.00194	CcSEcCtD
Albendazole—Vertigo—Paclitaxel—lung cancer	0.000162	0.00193	CcSEcCtD
Albendazole—Leukopenia—Paclitaxel—lung cancer	0.000161	0.00192	CcSEcCtD
Albendazole—Rash—Topotecan—lung cancer	0.000161	0.00192	CcSEcCtD
Albendazole—Hypersensitivity—Vinorelbine—lung cancer	0.000161	0.00192	CcSEcCtD
Albendazole—Dermatitis—Topotecan—lung cancer	0.000161	0.00192	CcSEcCtD
Albendazole—Vomiting—Erlotinib—lung cancer	0.000161	0.00192	CcSEcCtD
Albendazole—Thrombocytopenia—Cisplatin—lung cancer	0.00016	0.00191	CcSEcCtD
Albendazole—Headache—Topotecan—lung cancer	0.00016	0.00191	CcSEcCtD
Albendazole—Rash—Erlotinib—lung cancer	0.000159	0.0019	CcSEcCtD
Albendazole—Dermatitis—Erlotinib—lung cancer	0.000159	0.0019	CcSEcCtD
Albendazole—Skin disorder—Cisplatin—lung cancer	0.000159	0.00189	CcSEcCtD
Albendazole—Immune system disorder—Docetaxel—lung cancer	0.000158	0.00189	CcSEcCtD
Albendazole—Headache—Erlotinib—lung cancer	0.000158	0.00189	CcSEcCtD
Albendazole—Nausea—Vinblastine—lung cancer	0.000156	0.00186	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000155	0.00185	CcSEcCtD
Albendazole—Alopecia—Docetaxel—lung cancer	0.000155	0.00185	CcSEcCtD
Albendazole—ABCB1—lung—lung cancer	0.000153	0.00712	CbGeAlD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000152	0.00182	CcSEcCtD
Albendazole—Nausea—Topotecan—lung cancer	0.000152	0.00181	CcSEcCtD
Albendazole—Nausea—Erlotinib—lung cancer	0.00015	0.00179	CcSEcCtD
Albendazole—Pancytopenia—Methotrexate—lung cancer	0.00015	0.00179	CcSEcCtD
Albendazole—Neutropenia—Methotrexate—lung cancer	0.000148	0.00176	CcSEcCtD
Albendazole—Gastrointestinal pain—Irinotecan—lung cancer	0.000147	0.00176	CcSEcCtD
Albendazole—Thrombocytopenia—Etoposide—lung cancer	0.000147	0.00175	CcSEcCtD
Albendazole—Liver function test abnormal—Doxorubicin—lung cancer	0.000146	0.00174	CcSEcCtD
Albendazole—Skin disorder—Etoposide—lung cancer	0.000145	0.00174	CcSEcCtD
Albendazole—Dizziness—Vinorelbine—lung cancer	0.000144	0.00172	CcSEcCtD
Albendazole—Thrombocytopenia—Paclitaxel—lung cancer	0.000144	0.00172	CcSEcCtD
Albendazole—Skin disorder—Paclitaxel—lung cancer	0.000143	0.0017	CcSEcCtD
Albendazole—Abdominal pain—Irinotecan—lung cancer	0.000142	0.0017	CcSEcCtD
Albendazole—Body temperature increased—Irinotecan—lung cancer	0.000142	0.0017	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000139	0.00166	CcSEcCtD
Albendazole—Vomiting—Vinorelbine—lung cancer	0.000139	0.00166	CcSEcCtD
Albendazole—Body temperature increased—Gemcitabine—lung cancer	0.000139	0.00165	CcSEcCtD
Albendazole—Rash—Vinorelbine—lung cancer	0.000138	0.00164	CcSEcCtD
Albendazole—Dermatitis—Vinorelbine—lung cancer	0.000138	0.00164	CcSEcCtD
Albendazole—Headache—Vinorelbine—lung cancer	0.000137	0.00163	CcSEcCtD
Albendazole—Leukopenia—Docetaxel—lung cancer	0.000137	0.00163	CcSEcCtD
Albendazole—Hepatobiliary disease—Methotrexate—lung cancer	0.000133	0.00159	CcSEcCtD
Albendazole—Hypersensitivity—Irinotecan—lung cancer	0.000133	0.00158	CcSEcCtD
Albendazole—Agranulocytosis—Methotrexate—lung cancer	0.000131	0.00157	CcSEcCtD
Albendazole—Pancytopenia—Doxorubicin—lung cancer	0.00013	0.00155	CcSEcCtD
Albendazole—Nausea—Vinorelbine—lung cancer	0.00013	0.00155	CcSEcCtD
Albendazole—Body temperature increased—Cisplatin—lung cancer	0.000129	0.00154	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000129	0.00154	CcSEcCtD
Albendazole—Neutropenia—Doxorubicin—lung cancer	0.000128	0.00152	CcSEcCtD
Albendazole—Hepatitis—Methotrexate—lung cancer	0.000126	0.00151	CcSEcCtD
Albendazole—Urinary tract disorder—Methotrexate—lung cancer	0.000125	0.00149	CcSEcCtD
Albendazole—Urethral disorder—Methotrexate—lung cancer	0.000124	0.00148	CcSEcCtD
Albendazole—Gastrointestinal pain—Etoposide—lung cancer	0.000122	0.00146	CcSEcCtD
Albendazole—Thrombocytopenia—Docetaxel—lung cancer	0.000122	0.00145	CcSEcCtD
Albendazole—Skin disorder—Docetaxel—lung cancer	0.000121	0.00144	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000121	0.00144	CcSEcCtD
Albendazole—Hypersensitivity—Cisplatin—lung cancer	0.00012	0.00144	CcSEcCtD
Albendazole—Gastrointestinal pain—Paclitaxel—lung cancer	0.00012	0.00143	CcSEcCtD
Albendazole—Erythema multiforme—Methotrexate—lung cancer	0.000119	0.00142	CcSEcCtD
Albendazole—Dizziness—Irinotecan—lung cancer	0.000119	0.00142	CcSEcCtD
Albendazole—Urticaria—Etoposide—lung cancer	0.000119	0.00142	CcSEcCtD
Albendazole—Abdominal pain—Etoposide—lung cancer	0.000118	0.00141	CcSEcCtD
Albendazole—Body temperature increased—Etoposide—lung cancer	0.000118	0.00141	CcSEcCtD
Albendazole—Urticaria—Paclitaxel—lung cancer	0.000117	0.00139	CcSEcCtD
Albendazole—Body temperature increased—Paclitaxel—lung cancer	0.000116	0.00139	CcSEcCtD
Albendazole—Abdominal pain—Paclitaxel—lung cancer	0.000116	0.00139	CcSEcCtD
Albendazole—Hepatobiliary disease—Doxorubicin—lung cancer	0.000115	0.00137	CcSEcCtD
Albendazole—Vomiting—Irinotecan—lung cancer	0.000115	0.00137	CcSEcCtD
Albendazole—Immune system disorder—Methotrexate—lung cancer	0.000114	0.00136	CcSEcCtD
Albendazole—Agranulocytosis—Doxorubicin—lung cancer	0.000114	0.00136	CcSEcCtD
Albendazole—Rash—Irinotecan—lung cancer	0.000114	0.00135	CcSEcCtD
Albendazole—Dermatitis—Irinotecan—lung cancer	0.000113	0.00135	CcSEcCtD
Albendazole—Headache—Irinotecan—lung cancer	0.000113	0.00135	CcSEcCtD
Albendazole—Alopecia—Methotrexate—lung cancer	0.000112	0.00133	CcSEcCtD
Albendazole—Vomiting—Gemcitabine—lung cancer	0.000112	0.00133	CcSEcCtD
Albendazole—Rash—Gemcitabine—lung cancer	0.000111	0.00132	CcSEcCtD
Albendazole—Dermatitis—Gemcitabine—lung cancer	0.000111	0.00132	CcSEcCtD
Albendazole—Hypersensitivity—Etoposide—lung cancer	0.00011	0.00132	CcSEcCtD
Albendazole—Headache—Gemcitabine—lung cancer	0.00011	0.00131	CcSEcCtD
Albendazole—Hepatitis—Doxorubicin—lung cancer	0.000109	0.0013	CcSEcCtD
Albendazole—Hypersensitivity—Paclitaxel—lung cancer	0.000108	0.00129	CcSEcCtD
Albendazole—Urinary tract disorder—Doxorubicin—lung cancer	0.000108	0.00129	CcSEcCtD
Albendazole—Urethral disorder—Doxorubicin—lung cancer	0.000107	0.00128	CcSEcCtD
Albendazole—Nausea—Irinotecan—lung cancer	0.000107	0.00128	CcSEcCtD
Albendazole—ABCB1—lymph node—lung cancer	0.000105	0.00487	CbGeAlD
Albendazole—Nausea—Gemcitabine—lung cancer	0.000104	0.00124	CcSEcCtD
Albendazole—Vomiting—Cisplatin—lung cancer	0.000104	0.00124	CcSEcCtD
Albendazole—Erythema multiforme—Doxorubicin—lung cancer	0.000103	0.00123	CcSEcCtD
Albendazole—Rash—Cisplatin—lung cancer	0.000103	0.00123	CcSEcCtD
Albendazole—Dermatitis—Cisplatin—lung cancer	0.000103	0.00123	CcSEcCtD
Albendazole—Gastrointestinal pain—Docetaxel—lung cancer	0.000102	0.00121	CcSEcCtD
Albendazole—Dizziness—Etoposide—lung cancer	9.91e-05	0.00118	CcSEcCtD
Albendazole—Immune system disorder—Doxorubicin—lung cancer	9.88e-05	0.00118	CcSEcCtD
Albendazole—Vertigo—Methotrexate—lung cancer	9.88e-05	0.00118	CcSEcCtD
Albendazole—Abdominal pain—Docetaxel—lung cancer	9.84e-05	0.00117	CcSEcCtD
Albendazole—Body temperature increased—Docetaxel—lung cancer	9.84e-05	0.00117	CcSEcCtD
Albendazole—Leukopenia—Methotrexate—lung cancer	9.84e-05	0.00117	CcSEcCtD
Albendazole—Dizziness—Paclitaxel—lung cancer	9.71e-05	0.00116	CcSEcCtD
Albendazole—Nausea—Cisplatin—lung cancer	9.71e-05	0.00116	CcSEcCtD
Albendazole—Alopecia—Doxorubicin—lung cancer	9.66e-05	0.00115	CcSEcCtD
Albendazole—Vomiting—Etoposide—lung cancer	9.52e-05	0.00114	CcSEcCtD
Albendazole—Rash—Etoposide—lung cancer	9.44e-05	0.00113	CcSEcCtD
Albendazole—Dermatitis—Etoposide—lung cancer	9.44e-05	0.00113	CcSEcCtD
Albendazole—Headache—Etoposide—lung cancer	9.38e-05	0.00112	CcSEcCtD
Albendazole—Vomiting—Paclitaxel—lung cancer	9.34e-05	0.00111	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	9.3e-05	0.00111	CcSEcCtD
Albendazole—Rash—Paclitaxel—lung cancer	9.26e-05	0.0011	CcSEcCtD
Albendazole—Dermatitis—Paclitaxel—lung cancer	9.25e-05	0.0011	CcSEcCtD
Albendazole—Headache—Paclitaxel—lung cancer	9.2e-05	0.0011	CcSEcCtD
Albendazole—Hypersensitivity—Docetaxel—lung cancer	9.17e-05	0.00109	CcSEcCtD
Albendazole—Nausea—Etoposide—lung cancer	8.9e-05	0.00106	CcSEcCtD
Albendazole—Thrombocytopenia—Methotrexate—lung cancer	8.78e-05	0.00105	CcSEcCtD
Albendazole—Nausea—Paclitaxel—lung cancer	8.72e-05	0.00104	CcSEcCtD
Albendazole—Skin disorder—Methotrexate—lung cancer	8.72e-05	0.00104	CcSEcCtD
Albendazole—Vertigo—Doxorubicin—lung cancer	8.55e-05	0.00102	CcSEcCtD
Albendazole—Leukopenia—Doxorubicin—lung cancer	8.52e-05	0.00102	CcSEcCtD
Albendazole—Dizziness—Docetaxel—lung cancer	8.23e-05	0.000982	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.05e-05	0.00096	CcSEcCtD
Albendazole—Vomiting—Docetaxel—lung cancer	7.92e-05	0.000944	CcSEcCtD
Albendazole—Rash—Docetaxel—lung cancer	7.85e-05	0.000936	CcSEcCtD
Albendazole—Dermatitis—Docetaxel—lung cancer	7.84e-05	0.000936	CcSEcCtD
Albendazole—Headache—Docetaxel—lung cancer	7.8e-05	0.00093	CcSEcCtD
Albendazole—Thrombocytopenia—Doxorubicin—lung cancer	7.61e-05	0.000908	CcSEcCtD
Albendazole—Skin disorder—Doxorubicin—lung cancer	7.55e-05	0.0009	CcSEcCtD
Albendazole—Nausea—Docetaxel—lung cancer	7.39e-05	0.000882	CcSEcCtD
Albendazole—Gastrointestinal pain—Methotrexate—lung cancer	7.34e-05	0.000875	CcSEcCtD
Albendazole—Urticaria—Methotrexate—lung cancer	7.13e-05	0.00085	CcSEcCtD
Albendazole—Body temperature increased—Methotrexate—lung cancer	7.09e-05	0.000846	CcSEcCtD
Albendazole—Abdominal pain—Methotrexate—lung cancer	7.09e-05	0.000846	CcSEcCtD
Albendazole—Hypersensitivity—Methotrexate—lung cancer	6.61e-05	0.000789	CcSEcCtD
Albendazole—Gastrointestinal pain—Doxorubicin—lung cancer	6.35e-05	0.000758	CcSEcCtD
Albendazole—Urticaria—Doxorubicin—lung cancer	6.17e-05	0.000736	CcSEcCtD
Albendazole—Abdominal pain—Doxorubicin—lung cancer	6.14e-05	0.000733	CcSEcCtD
Albendazole—Body temperature increased—Doxorubicin—lung cancer	6.14e-05	0.000733	CcSEcCtD
Albendazole—Dizziness—Methotrexate—lung cancer	5.93e-05	0.000708	CcSEcCtD
Albendazole—Hypersensitivity—Doxorubicin—lung cancer	5.72e-05	0.000683	CcSEcCtD
Albendazole—Vomiting—Methotrexate—lung cancer	5.7e-05	0.000681	CcSEcCtD
Albendazole—Rash—Methotrexate—lung cancer	5.66e-05	0.000675	CcSEcCtD
Albendazole—Dermatitis—Methotrexate—lung cancer	5.65e-05	0.000674	CcSEcCtD
Albendazole—Headache—Methotrexate—lung cancer	5.62e-05	0.000671	CcSEcCtD
Albendazole—Nausea—Methotrexate—lung cancer	5.33e-05	0.000636	CcSEcCtD
Albendazole—Dizziness—Doxorubicin—lung cancer	5.14e-05	0.000613	CcSEcCtD
Albendazole—Vomiting—Doxorubicin—lung cancer	4.94e-05	0.000589	CcSEcCtD
Albendazole—Rash—Doxorubicin—lung cancer	4.9e-05	0.000584	CcSEcCtD
Albendazole—Dermatitis—Doxorubicin—lung cancer	4.89e-05	0.000584	CcSEcCtD
Albendazole—Headache—Doxorubicin—lung cancer	4.87e-05	0.000581	CcSEcCtD
Albendazole—Nausea—Doxorubicin—lung cancer	4.61e-05	0.000551	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.37e-05	0.000284	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CKB—lung cancer	1.37e-05	0.000284	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.36e-05	0.000283	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MYC—lung cancer	1.36e-05	0.000282	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.35e-05	0.00028	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	1.32e-05	0.000274	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.32e-05	0.000274	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.31e-05	0.000271	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AZIN2—lung cancer	1.31e-05	0.000271	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—RRM1—lung cancer	1.3e-05	0.000269	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTA3—lung cancer	1.3e-05	0.000269	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CNDP2—lung cancer	1.29e-05	0.000267	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM2—lung cancer	1.29e-05	0.000267	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLBD1—lung cancer	1.28e-05	0.000266	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	1.26e-05	0.000262	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTMR3—lung cancer	1.25e-05	0.000259	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.22e-05	0.000254	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—B4GALT5—lung cancer	1.22e-05	0.000253	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PGAM1—lung cancer	1.22e-05	0.000253	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.19e-05	0.000247	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.19e-05	0.000247	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTA4—lung cancer	1.19e-05	0.000246	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HSD17B10—lung cancer	1.17e-05	0.000243	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2A7—lung cancer	1.16e-05	0.000241	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTA2—lung cancer	1.16e-05	0.00024	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.15e-05	0.000239	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.15e-05	0.000239	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SDC4—lung cancer	1.14e-05	0.000236	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—lung cancer	1.12e-05	0.000232	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTA1—lung cancer	1.12e-05	0.000231	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ATP5H—lung cancer	1.11e-05	0.00023	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—POMC—lung cancer	1.11e-05	0.00023	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCC3—lung cancer	1.1e-05	0.000229	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.1e-05	0.000228	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CKB—lung cancer	1.09e-05	0.000226	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKR1C1—lung cancer	1.07e-05	0.000222	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.07e-05	0.000221	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.04e-05	0.000215	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—UGT1A1—lung cancer	1.04e-05	0.000215	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—RRM1—lung cancer	1.04e-05	0.000215	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTA3—lung cancer	1.04e-05	0.000215	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CNDP2—lung cancer	1.03e-05	0.000213	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM2—lung cancer	1.03e-05	0.000213	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GNG11—lung cancer	1e-05	0.000207	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTMR3—lung cancer	9.98e-06	0.000207	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.95e-06	0.000206	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLBD1—lung cancer	9.9e-06	0.000205	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	9.88e-06	0.000205	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	9.83e-06	0.000204	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—B4GALT5—lung cancer	9.74e-06	0.000202	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PGAM1—lung cancer	9.73e-06	0.000202	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	9.56e-06	0.000198	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALDOA—lung cancer	9.52e-06	0.000197	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTA4—lung cancer	9.48e-06	0.000197	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	9.35e-06	0.000194	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2A7—lung cancer	9.28e-06	0.000192	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NCOA3—lung cancer	9.24e-06	0.000192	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTA2—lung cancer	9.23e-06	0.000192	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.08e-06	0.000188	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SDC4—lung cancer	9.08e-06	0.000188	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HSD17B10—lung cancer	9.06e-06	0.000188	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCG2—lung cancer	8.99e-06	0.000186	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ADCY1—lung cancer	8.99e-06	0.000186	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTA1—lung cancer	8.91e-06	0.000185	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	8.83e-06	0.000183	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HPGDS—lung cancer	8.82e-06	0.000183	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ENO2—lung cancer	8.82e-06	0.000183	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCC3—lung cancer	8.81e-06	0.000183	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPP2R1B—lung cancer	8.76e-06	0.000182	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.64e-06	0.000179	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTT1—lung cancer	8.55e-06	0.000177	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKR1C1—lung cancer	8.53e-06	0.000177	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GCLC—lung cancer	8.45e-06	0.000175	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP2A6—lung cancer	8.45e-06	0.000175	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CKB—lung cancer	8.42e-06	0.000175	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.42e-06	0.000175	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—UGT1A1—lung cancer	8.28e-06	0.000172	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—RRM1—lung cancer	8.27e-06	0.000172	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA3—lung cancer	8.27e-06	0.000172	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	8.11e-06	0.000168	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ENO1—lung cancer	8.01e-06	0.000166	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GNG11—lung cancer	7.99e-06	0.000166	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.98e-06	0.000166	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CNDP2—lung cancer	7.92e-06	0.000164	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM2—lung cancer	7.92e-06	0.000164	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.88e-06	0.000163	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	7.85e-06	0.000163	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—B4GALT5—lung cancer	7.78e-06	0.000161	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTMR3—lung cancer	7.7e-06	0.00016	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALDOA—lung cancer	7.6e-06	0.000158	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA4—lung cancer	7.56e-06	0.000157	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	7.55e-06	0.000157	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PGAM1—lung cancer	7.51e-06	0.000156	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	7.39e-06	0.000153	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NCOA3—lung cancer	7.38e-06	0.000153	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA2—lung cancer	7.37e-06	0.000153	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP2E1—lung cancer	7.19e-06	0.000149	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCG2—lung cancer	7.18e-06	0.000149	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ADCY1—lung cancer	7.18e-06	0.000149	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2A7—lung cancer	7.16e-06	0.000149	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA1—lung cancer	7.11e-06	0.000148	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NQO1—lung cancer	7.11e-06	0.000147	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ENO2—lung cancer	7.04e-06	0.000146	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HPGDS—lung cancer	7.04e-06	0.000146	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCC3—lung cancer	7.03e-06	0.000146	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SDC4—lung cancer	7.01e-06	0.000145	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPP2R1B—lung cancer	7e-06	0.000145	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.96e-06	0.000144	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.9e-06	0.000143	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTT1—lung cancer	6.83e-06	0.000142	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKR1C1—lung cancer	6.81e-06	0.000141	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GCLC—lung cancer	6.75e-06	0.00014	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2A6—lung cancer	6.75e-06	0.00014	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	6.63e-06	0.000137	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—UGT1A1—lung cancer	6.61e-06	0.000137	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—STK11—lung cancer	6.41e-06	0.000133	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ENO1—lung cancer	6.4e-06	0.000133	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	6.39e-06	0.000133	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA3—lung cancer	6.38e-06	0.000132	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—RRM1—lung cancer	6.38e-06	0.000132	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GNG11—lung cancer	6.38e-06	0.000132	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	6.34e-06	0.000132	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDOA—lung cancer	6.07e-06	0.000126	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.01e-06	0.000125	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—B4GALT5—lung cancer	6e-06	0.000124	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.99e-06	0.000124	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTP1—lung cancer	5.93e-06	0.000123	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOA3—lung cancer	5.89e-06	0.000122	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA4—lung cancer	5.84e-06	0.000121	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.79e-06	0.00012	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CAT—lung cancer	5.77e-06	0.00012	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2E1—lung cancer	5.74e-06	0.000119	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.73e-06	0.000119	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCG2—lung cancer	5.73e-06	0.000119	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ADCY1—lung cancer	5.73e-06	0.000119	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA2—lung cancer	5.69e-06	0.000118	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NQO1—lung cancer	5.68e-06	0.000118	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HPGDS—lung cancer	5.62e-06	0.000117	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ENO2—lung cancer	5.62e-06	0.000117	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCB1—lung cancer	5.61e-06	0.000116	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPP2R1B—lung cancer	5.59e-06	0.000116	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.51e-06	0.000114	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TYMS—lung cancer	5.51e-06	0.000114	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA1—lung cancer	5.49e-06	0.000114	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTT1—lung cancer	5.45e-06	0.000113	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—lung cancer	5.45e-06	0.000113	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCC3—lung cancer	5.43e-06	0.000113	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.41e-06	0.000112	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2A6—lung cancer	5.39e-06	0.000112	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GCLC—lung cancer	5.39e-06	0.000112	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.37e-06	0.000111	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKR1C1—lung cancer	5.26e-06	0.000109	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ERCC2—lung cancer	5.12e-06	0.000106	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—STK11—lung cancer	5.12e-06	0.000106	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ENO1—lung cancer	5.11e-06	0.000106	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—UGT1A1—lung cancer	5.1e-06	0.000106	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.09e-06	0.000106	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.03e-06	0.000104	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GNG11—lung cancer	4.92e-06	0.000102	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTP1—lung cancer	4.73e-06	9.82e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDOA—lung cancer	4.68e-06	9.72e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CAT—lung cancer	4.61e-06	9.56e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2E1—lung cancer	4.58e-06	9.51e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOA3—lung cancer	4.55e-06	9.43e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NQO1—lung cancer	4.53e-06	9.4e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.44e-06	9.2e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOA1—lung cancer	4.43e-06	9.19e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCG2—lung cancer	4.42e-06	9.18e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADCY1—lung cancer	4.42e-06	9.18e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TYMS—lung cancer	4.4e-06	9.13e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.4e-06	9.12e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—lung cancer	4.35e-06	9.02e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ENO2—lung cancer	4.34e-06	9e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HPGDS—lung cancer	4.34e-06	9e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.31e-06	8.94e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.24e-06	8.8e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTT1—lung cancer	4.21e-06	8.73e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GCLC—lung cancer	4.16e-06	8.63e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2A6—lung cancer	4.16e-06	8.63e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1A1—lung cancer	4.12e-06	8.55e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ERCC2—lung cancer	4.09e-06	8.48e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—STK11—lung cancer	4.08e-06	8.47e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CG—lung cancer	4.04e-06	8.39e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ENO1—lung cancer	3.94e-06	8.18e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—POMC—lung cancer	3.85e-06	7.99e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.83e-06	7.95e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTP1—lung cancer	3.78e-06	7.84e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CREBBP—lung cancer	3.75e-06	7.78e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CAT—lung cancer	3.68e-06	7.63e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.66e-06	7.58e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCB1—lung cancer	3.58e-06	7.42e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CD—lung cancer	3.56e-06	7.37e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOA1—lung cancer	3.54e-06	7.34e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2E1—lung cancer	3.54e-06	7.34e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TYMS—lung cancer	3.51e-06	7.29e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—lung cancer	3.51e-06	7.28e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NQO1—lung cancer	3.5e-06	7.25e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—lung cancer	3.47e-06	7.2e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1A1—lung cancer	3.29e-06	6.83e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ERCC2—lung cancer	3.27e-06	6.77e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CG—lung cancer	3.23e-06	6.7e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—STK11—lung cancer	3.15e-06	6.54e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CB—lung cancer	3.1e-06	6.43e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—POMC—lung cancer	3.08e-06	6.38e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—lung cancer	3.07e-06	6.37e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CREBBP—lung cancer	3e-06	6.21e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTP1—lung cancer	2.92e-06	6.05e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CD—lung cancer	2.84e-06	5.89e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CAT—lung cancer	2.84e-06	5.89e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOA1—lung cancer	2.82e-06	5.86e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—lung cancer	2.8e-06	5.81e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCB1—lung cancer	2.76e-06	5.73e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TYMS—lung cancer	2.71e-06	5.62e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.7e-06	5.61e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—lung cancer	2.68e-06	5.56e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTEN—lung cancer	2.68e-06	5.55e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CG—lung cancer	2.58e-06	5.35e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—EP300—lung cancer	2.55e-06	5.3e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1A1—lung cancer	2.54e-06	5.27e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ERCC2—lung cancer	2.52e-06	5.23e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CB—lung cancer	2.48e-06	5.13e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—POMC—lung cancer	2.45e-06	5.09e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—lung cancer	2.45e-06	5.09e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CREBBP—lung cancer	2.39e-06	4.96e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CD—lung cancer	2.27e-06	4.7e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—lung cancer	2.24e-06	4.64e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOA1—lung cancer	2.18e-06	4.52e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTEN—lung cancer	2.14e-06	4.44e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—EP300—lung cancer	2.04e-06	4.23e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CG—lung cancer	1.99e-06	4.13e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CB—lung cancer	1.98e-06	4.1e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—lung cancer	1.96e-06	4.06e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—POMC—lung cancer	1.89e-06	3.93e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—lung cancer	1.89e-06	3.92e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CREBBP—lung cancer	1.85e-06	3.83e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CD—lung cancer	1.75e-06	3.63e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—lung cancer	1.73e-06	3.58e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTEN—lung cancer	1.71e-06	3.54e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—EP300—lung cancer	1.63e-06	3.38e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—lung cancer	1.54e-06	3.2e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CB—lung cancer	1.53e-06	3.16e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—lung cancer	1.51e-06	3.13e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—lung cancer	1.51e-06	3.13e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTEN—lung cancer	1.32e-06	2.73e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—EP300—lung cancer	1.26e-06	2.61e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—lung cancer	1.23e-06	2.56e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—lung cancer	1.2e-06	2.5e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—lung cancer	9.84e-07	2.04e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—lung cancer	9.3e-07	1.93e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—lung cancer	7.59e-07	1.58e-05	CbGpPWpGaD
